SUN VALLEY, CA--(Marketwire - January 25, 2010) -
Highlighted Links |
|
XTend Medical (PINKSHEETS: XMDC), a company that specializes in delivering life changing medical technology to healthcare organizations globally, announced today that due to the recent acquisition of the BioHarp Business, they are required to expedite their process to become a fully reporting company.
The company released the following statement:
“Our corporate counsel has notified us that due to the valuation of the recent acquisition of the BioHarp Business, in a restricted stock transaction, XTend Medical is now required to take the necessary action to become a fully-reporting company. Due to the requirements based on the Securities and Exchange Act of 1934, XTend is now required to file a Form 10 with the SEC and move to the OTCBB or higher exchange. The company is working closely with our counsel to file the required forms and have narrowed our auditing company choices to two companies. We’re working with our CPA to prepare our end of year and fiscal filings so we can be prepared for the auditors to begin their work. We feel confident that based on our recent acquisition of the BioHarp business and its subsequent valuation, the company believes it will be commence trading on the OTCBB within 6-8 weeks. This will create a great opportunity for the company to gain exposure in global trading markets,” Mr. Paul D. Lisenby stated.
Mr. Lisenby further added, “We ran into a major problem with our new website launch on Friday. The website developer had problems with water damage due to the storms here in Southern California. While we were promised the data could be recovered in time for the launch, this was just not the case and the entire site will now have to be rebuilt. We’re placing a temporary site up with as much information as we can so as to keep our shareholders informed. XTend is hopeful the new site can be up within the next week or so. We apologize if this has caused any issues but unfortunately this was simply out of the hands of the management of the company.”
About XTend Medical
XTend Medical is a company that specializes in the sales, manufacturing and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their recent acquisition of the BioHarp medical device will assist the company in becoming known as a leader in the healthcare sector globally. For further information, please contact them at info@bioharpunius.com or visit their website at www.bioharpunius.com.
Forward-Looking Statements
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.
CONTACT
XTend Medical Corporation
info@bioharpunius.com